TY - JOUR T1 - Effects of the COVID-19 pandemic on a cohort of patients with vein occlusion JO - Revista Clínica Española (English Edition) T2 - AU - García Palacios,J.D. AU - Puente Ruiz,N. AU - Napal Lecumberri,J.J. AU - Hernández Hernández,J.L. SN - 22548874 M3 - 10.1016/j.rceng.2021.06.003 DO - 10.1016/j.rceng.2021.06.003 UR - https://www.revclinesp.es/en-effects-covid-19-pandemic-on-cohort-articulo-S2254887421001570 AB - Background and objectivesA new coronavirus disease in humans, COVID-19, caused by SARS-CoV-2, emerged in December 2019. It has been associated with the development of thrombotic phenomena. Retinal vein occlusion (RVO) is mainly a consequence of vascular risk factors (VRF). This study aimed to analyze cases of COVID-19 in a cohort of patients with RVO (Valdecilla cohort). Patients and methodsBetween December 2008 and December 2020, 429 patients with RVO were attended to in our clinic. Ten patients had COVID-19, one of which did not have VRF or thrombophilia. The remaining nine patients had RVO prior to the infection and VRF, six had carotid atherosclerosis, and four had antiphospholipid syndrome. The infection did not cause thrombotic phenomena in any of them. ConclusionsRVO is a rare manifestation of COVID-19. In our cohort of patients with RVO, COVID-19 disease did not lead to thrombotic events. ER -